Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)

Joy N. Tsai(Harvard University), Benjamin Z. Leder(Massachusetts General Hospital), Alexander V. Uihlein(Harvard University), Nicholas P. Derrico(Massachusetts General Hospital), H. Lee(Massachusetts General Hospital), Robert M. Neer(Brigham and Women's Hospital), Sherri‐Ann M. Burnett‐Bowie(Harvard University), Mary Bouxsein(Beth Israel Deaconess Medical Center)
The Journal of Clinical Endocrinology & Metabolism
March 10, 2016
Cited by 120


Related Papers